Fourth generation Solitaire X revascularization device launched in US

Medtronic has launched its fourth generation Solitaire X revascularization device, which mechanically removes blood clots from blocked vessels in the brain to restore blood flow in patients suffering an acute ischemic stroke with large vessel occlusion. It features an optimized delivery system for improved efficiency, while retaining the technical features that have made the Solitaire family of revascularization devices clinically proven and highly effective.
A 160cm long microcatheter used for the delivery of all sizes of Solitaire X, Phenom 21 Catheter, has also been launched. Together, these two devices are expected to provide a low clot crossing profile, with smooth delivery to occlusions in distal vessels as small as 2.0mm.
Professor Dr. Reza Jahan, UCLA radiology and neurosurgery, said: “Medtronic continues to deliver technological innovations to advance stroke treatment. As a long-time Solitaire user, I am impressed with the ease of the Solitaire X delivery. I find that Solitaire X 6×40 device combined with Phenom 21 catheter provides smooth navigation especially when working with complicated anatomy.”
Stacey Pugh, Medtronic neurovascular business vice president and general manager, said: “Our commitment to enable physicians to improve outcomes for stroke patients worldwide will always be our motivation. The net result of that commitment is the launch of a 4th generation device, Solitaire X, which marks 10 years of innovation in stroke therapy.”